{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.5399766, "regularMarketPrice": 10.9, "exchange": "NGM", "shortName": "GH Research PLC", "longName": "GH Research PLC", "messageBoardId": "finmb_707594028", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "currency": "USD", "marketState": "PRE", "firstTradeDateMilliseconds": 1624627800000, "priceHint": 2, "fiftyTwoWeekLowChange": 5.2, "fiftyTwoWeekLowChangePercent": 0.9122807, "fiftyTwoWeekRange": "5.7 - 17.414", "fiftyTwoWeekHighChange": -6.514, "fiftyTwoWeekHighChangePercent": -0.37406686, "fiftyTwoWeekLow": 5.7, "fiftyTwoWeekHigh": 17.414, "trailingAnnualDividendRate": 0.0, "epsTrailingTwelveMonths": -0.47, "epsForward": -1.3, "epsCurrentYear": -0.97, "priceEpsCurrentYear": -11.237113, "sharesOutstanding": 52020800, "bookValue": 4.802, "fiftyDayAverage": 8.4804, "fiftyDayAverageChange": 2.4195995, "fiftyDayAverageChangePercent": 0.28531668, "twoHundredDayAverage": 10.492545, "twoHundredDayAverageChange": 0.4074545, "twoHundredDayAverageChangePercent": 0.03883276, "marketCap": 567026688, "forwardPE": -8.384615, "priceToBook": 2.2698874, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.2699995, "regularMarketTime": 1684180805, "regularMarketDayHigh": 11.1183, "regularMarketDayRange": "10.6 - 11.1183", "regularMarketDayLow": 10.6, "regularMarketVolume": 34361, "regularMarketPreviousClose": 10.63, "bid": 0.0, "ask": 0.0, "bidSize": 10, "askSize": 8, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 10.81, "averageDailyVolume3Month": 71040, "averageDailyVolume10Day": 46640, "trailingAnnualDividendYield": 0.0, "displayName": "GH Research", "symbol": "GHRS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Joshua Dawson House", "address2": "Dawson Street", "city": "Dublin", "zip": "D02 RY95", "country": "Ireland", "phone": "353 1 437 8334", "website": "https://www.ghres.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Florian  Schonharting M.Sc. (Econ)", "age": 53, "title": "Co-Founder & Non-Exec. Chairman", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Theis  Terwey M.D.", "age": 46, "title": "Co-Founder & CEO", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Magnus  Halle", "age": 25, "title": "Co-Founder & MD of Ireland", "yearBorn": 1997, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Julie  Ryan F.C.A.", "age": 36, "title": "VP of Fin.", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron  Cameron", "age": 37, "title": "VP of Technical Devel. & Operational Planning", "yearBorn": 1985, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}